RELAPSE

This study is testing whether combining two drugs, epcoritamab and loncastuximab tesirine, is safe and effective for adults with large B-cell lymphoma that has returned or stopped responding to prior treatments. The main goal is to see if the combination can reduce or eliminate c…

This study tests whether adding regular motivational talks to standard care helps people with alcohol addiction stay sober longer after leaving the hospital. Researchers will compare two groups of 104 adults: one receiving motivational interviews every two weeks for four months, …

This study is testing a combination of four medications to control multiple myeloma that has returned or stopped responding to prior treatments. It will involve about 43 adults whose cancer progressed after standard therapies. The main goal is to see how well this specific drug c…

This early-stage study is testing the safety of a new cell therapy for pancreatic cancer that has come back after standard treatment. Doctors modify a patient's own immune cells (called CAR-T cells) to target a protein found on pancreatic cancer cells. The main goal is to find a …

This early-stage study is testing the safety of a new type of treatment called CAR-T cell therapy for adults with triple negative breast cancer that has returned or stopped responding to other treatments. Doctors will collect a patient's own immune cells, modify them in a lab to …

This study is testing a new type of cell therapy for Hodgkin lymphoma that has come back or hasn't responded to standard treatments. Researchers are modifying a patient's own immune cells to better find and attack the cancer cells. The trial aims to find a safe dose and see how w…

This study is testing a new, experimental treatment called CAR-T cell therapy for people with head and neck cancer that has come back or stopped responding to standard treatments. The main goals are to find a safe dose and see what side effects occur. Researchers will collect a p…